D. Pernkopf

Attenuated proliferation and trans-differentiation of prostatic stromal cells indicate suitability of phosphodiesterase type 5 inhibitors for prevention and treatment of benign prostatic hyperplasia.

G. Untergasser, E. Plas, P. Berger, 2010, Endocrinology.

Uroflow nomogram for male adolescents.

K. Kubin, E. Plas, T. Lang, 2005, The Journal of urology.